Controlling Conjugated Antibodies at the Molecular Level for Active Targeting Nanoparticles toward HER2-Positive Cancer Cells-Reference-Cited by-同舟云学术

Controlling Conjugated Antibodies at the Molecular Level for Active Targeting Nanoparticles toward HER2-Positive Cancer Cells

Author:

Li Mingyang¹²,Dong Jicheng¹²,Cheng Fang¹²^ORCID,Li Chunmei¹²,Wang Huanan³^ORCID,Sun Tao⁴,He Wei¹⁵^ORCID,Wang Qing¹²^ORCID

Affiliation:

1. State Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian, Liaoning 116023, China

2. Department of Pharmacy, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China

3. School of Bioengineering, Dalian University of Technology, Dalian, Liaoning 116023, China

4. Department of Breast Medicine, Cancer Hospital of China Medical University, Liaoning Cancer Hospital, Shenyang, Liaoning 110042, China

5. Department of Polymer Science & Engineering, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116023, China

Funder

Ministry of Education of the People's Republic of China

Ministry of Science and Technology of the People's Republic of China

National Natural Science Foundation of China

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Pharmaceutical Science,Molecular Medicine

Link

Reference48 articles.

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献